These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1642 related articles for article (PubMed ID: 32746936)

  • 1. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
    Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
    Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Nephrocyte Injury and Proteinuria in a Diabetic Nephropathy Rat Model.
    Chen L; Xiang E; Li C; Han B; Zhang Q; Rao W; Xiao C; Wu D
    J Diabetes Res; 2020; 2020():8035853. PubMed ID: 32405507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment.
    Li Y; Liu J; Liao G; Zhang J; Chen Y; Li L; Li L; Liu F; Chen B; Guo G; Wang C; Yang L; Cheng J; Lu Y
    Int J Mol Med; 2018 May; 41(5):2629-2639. PubMed ID: 29484379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intervention for early diabetic nephropathy by mesenchymal stem cells in a preclinical nonhuman primate model.
    An X; Liao G; Chen Y; Luo A; Liu J; Yuan Y; Li L; Yang L; Wang H; Liu F; Yang G; Yi S; Li Y; Cheng J; Lu Y
    Stem Cell Res Ther; 2019 Dec; 10(1):363. PubMed ID: 31791397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate renal fibrosis in diabetic nephropathy by targeting Hedgehog/SMO signaling.
    Zhang K; Zheng S; Wu J; He J; Ouyang Y; Ao C; Lang R; Jiang Y; Yang Y; Xiao H; Li Y; Li M; Wang H; Li C; Wu D
    FASEB J; 2024 Apr; 38(7):e23599. PubMed ID: 38572590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of diabetic nephropathy in mice by a single intravenous injection of human mesenchymal stromal cells at early and later disease stages is associated with restoration of autophagy.
    He J; Liu B; Du X; Wei Y; Kong D; Feng B; Guo R; Asiamah EA; Griffin MD; Hynes SO; Shen S; Liu Y; Cui H; Ma J; O'Brien T
    Stem Cell Res Ther; 2024 Mar; 15(1):66. PubMed ID: 38443965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse Umbilical Cord Mesenchymal Stem Cell Paracrine Alleviates Renal Fibrosis in Diabetic Nephropathy by Reducing Myofibroblast Transdifferentiation and Cell Proliferation and Upregulating MMPs in Mesangial Cells.
    Li H; Rong P; Ma X; Nie W; Chen Y; Zhang J; Dong Q; Yang M; Wang W
    J Diabetes Res; 2020; 2020():3847171. PubMed ID: 32455132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines.
    Bai Y; Wang J; He Z; Yang M; Li L; Jiang H
    Med Sci Monit; 2019 Apr; 25():3069-3076. PubMed ID: 31023998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy.
    Carmona M; Paco-Meza LM; Ortega R; Cañadillas S; Caballero-Villarraso J; Blanco A; Herrera C
    Pathol Res Pract; 2022 Feb; 230():153756. PubMed ID: 35032832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization.
    Zhang Y; Le X; Zheng S; Zhang K; He J; Liu M; Tu C; Rao W; Du H; Ouyang Y; Li C; Wu D
    Stem Cell Res Ther; 2022 Apr; 13(1):171. PubMed ID: 35477552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of xenogeneic transplantation of umbilical cord-derived mesenchymal stem cells combined with irbesartan on renal podocyte damage in diabetic rats.
    Meng J; Gao X; Liu X; Zheng W; Wang Y; Wang Y; Sun Z; Yin X; Zhou X
    Stem Cell Res Ther; 2024 Jul; 15(1):239. PubMed ID: 39080783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action.
    Park JH; Hwang I; Hwang SH; Han H; Ha H
    Diabetes Res Clin Pract; 2012 Dec; 98(3):465-73. PubMed ID: 23026513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress.
    Lv S; Cheng J; Sun A; Li J; Wang W; Guan G; Liu G; Su M
    Diabetes Res Clin Pract; 2014 Apr; 104(1):143-54. PubMed ID: 24513119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration.
    Lv SS; Liu G; Wang JP; Wang WW; Cheng J; Sun AL; Liu HY; Nie HB; Su MR; Guan GJ
    Int Immunopharmacol; 2013 Oct; 17(2):275-82. PubMed ID: 23791972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Umbilical Cord Mesenchymal Stem Cells Promote Macrophage PD-L1 Expression and Attenuate Acute Lung Injury in Mice.
    Tu C; Wang Z; Xiang E; Zhang Q; Zhang Y; Wu P; Li C; Wu D
    Curr Stem Cell Res Ther; 2022; 17(6):564-575. PubMed ID: 35086457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes.
    Nagaishi K; Mizue Y; Chikenji T; Otani M; Nakano M; Konari N; Fujimiya M
    Sci Rep; 2016 Oct; 6():34842. PubMed ID: 27721418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats.
    Sun X; Hao H; Han Q; Song X; Liu J; Dong L; Han W; Mu Y
    Stem Cell Res Ther; 2017 Nov; 8(1):241. PubMed ID: 29096724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells modified with angiotensin-converting enzyme 2 are superior for amelioration of glomerular fibrosis in diabetic nephropathy.
    Liu Q; Lv S; Liu J; Liu S; Wang Y; Liu G
    Diabetes Res Clin Pract; 2020 Apr; 162():108093. PubMed ID: 32109518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation.
    Chang JW; Tsai HL; Chen CW; Yang HW; Yang AH; Yang LY; Wang PS; Ng YY; Lin TL; Lee OK
    J Cell Mol Med; 2012 Dec; 16(12):2935-49. PubMed ID: 22862802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase.
    Zhang L; Li Y; Guan CY; Tian S; Lv XD; Li JH; Ma X; Xia HF
    Stem Cell Res Ther; 2018 Feb; 9(1):36. PubMed ID: 29433563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 83.